Back to YC Companies
64x Bio
Summer 2018
Active
Enabling next generation medicines. A comprehensive platform and…
25 people View on YC
64x Bio at a glance
- Y Combinator batch
- Summer 2018
- Status
- Active
- Industry
- Healthcare
- Team size
- 25 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About 64x Bio
The future of medicine is taking shape, but scaling it remains a challenge. Some of the biggest breakthroughs in next generation therapies are being held back by manufacturing constraints. The science is moving fast, but the infrastructure is still catching up. Our VectorSelect platform is designed to unlock the scale these therapies need to survive. We combine massively parallelized screens with computational insights to engineer high yield cell lines and production technologies — accelerating the manufacturing of advanced therapies from the inside out.
Tags:
Gene Therapy
Machine Learning